 |
||||||||||||||||||
|
|
||||||||||||||||||
|
In 2009, we’re looking to deliver scholarships to more deserving recipients. Could you be one of them? For a chance at winning, simply apply by April 10, 2009.
Spread the word. Tell your friends and family members about the program. In 2008, we awarded scholarships to 30 students, acknowledging their accomplishments and supporting their future endeavors. Meet the winners. Learn more about resources for people living with epilepsy at epilepsyadvocate.com. |
|||||||||||||||||
IMPORTANT SAFETY INFORMATION
Keppra® is a medicine that is used with other medicines to treat primary
generalized tonic-clonic seizures in adults and children 6 years of age and older with
idiopathic generalized epilepsy, myoclonic seizures in patients 12 years of age and older
with juvenile myoclonic epilepsy, and partial onset seizures in patients 4 years of age and
older with epilepsy.
Keppra® is generally well tolerated but may not be for everyone. Keppra® may cause extreme sleepiness, tiredness, weakness or problems with muscle coordination. You should call your healthcare provider right away if you experience any of these problems or if you experience mood and behavior changes such as aggression, agitation, anger, anxiety, apathy, mood swings, depression, hostility, and irritability. A few people may get psychotic symptoms such as hallucinations, delusions, and unusual behavior. A few people may get thoughts of suicide. The most common side effects with Keppra in adults are sleepiness, weakness, dizziness, and infection. In children, the most common side effects are sleepiness, accidental injury, hostility, irritability, and weakness.
Please see Prescribing Information for additional Patient Information. This information does not take the place of talking with your healthcare provider about your condition or your treatment.
